Stock Track | Attovia Therapeutics Soars 23.53% in Nasdaq Debut After Upsized $289 Million IPO

Stock Track

Aug 06

Shares of Attovia Therapeutics (ATTO) soared 23.53% in intraday trading on Wednesday, marking a strong debut on the Nasdaq after the company's upsized initial public offering.

The biotech firm priced its IPO at $17.00 per share, the top of the marketed range, and increased the deal size to 17 million shares from the originally planned 12.5 million, raising approximately $289 million. The offering was managed by Morgan Stanley, Leerink Partners, Citigroup, and RBC Capital Markets.

Pre-market indications had pointed to a robust open, with the stock expected to start trading between $20 and $24, reflecting heightened investor demand for Attovia's pipeline of immune-mediated disease therapies, including its lead program ATTO-1310 for chronic pruritic conditions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1155329520"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1155329520\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1155329520?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-06 00:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1155329520","market":"sg","top_or_hot":-1,"title":"Stock Track | Attovia Therapeutics Soars 23.53% in Nasdaq Debut After Upsized $289 Million IPO","media":"Stock Track","content":"<p>Shares of Attovia Therapeutics (ATTO) soared 23.53% in intraday trading on Wednesday, marking a strong debut on the Nasdaq after the company's upsized initial public offering.</p><p>The biotech firm priced its IPO at $17.00 per share, the top of the marketed range, and increased the deal size to 17 million shares from the originally planned 12.5 million, raising approximately $289 million. The offering was managed by Morgan Stanley, Leerink Partners, Citigroup, and RBC Capital Markets.</p><p>Pre-market indications had pointed to a robust open, with the stock expected to start trading between $20 and $24, reflecting heightened investor demand for Attovia's pipeline of immune-mediated disease therapies, including its lead program ATTO-1310 for chronic pruritic conditions.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Attovia Therapeutics Soars 23.53% in Nasdaq Debut After Upsized $289 Million IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Attovia Therapeutics Soars 23.53% in Nasdaq Debut After Upsized $289 Million IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-08-06 00:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Attovia Therapeutics (ATTO) soared 23.53% in intraday trading on Wednesday, marking a strong debut on the Nasdaq after the company's upsized initial public offering.</p><p>The biotech firm priced its IPO at $17.00 per share, the top of the marketed range, and increased the deal size to 17 million shares from the originally planned 12.5 million, raising approximately $289 million. The offering was managed by Morgan Stanley, Leerink Partners, Citigroup, and RBC Capital Markets.</p><p>Pre-market indications had pointed to a robust open, with the stock expected to start trading between $20 and $24, reflecting heightened investor demand for Attovia's pipeline of immune-mediated disease therapies, including its lead program ATTO-1310 for chronic pruritic conditions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ATTO","symbol_name":"Attovia Therapeutics","start_time":0,"source_url":"","article_id":"1155329520","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1155329520","pubTimestamp":1785946848,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Attovia Therapeutics (ATTO) soared 23.53% in intraday trading on Wednesday, marking a strong debut on the Nasdaq after the company's upsized initial public offering.The biotech firm priced...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ATTO":"Attovia Therapeutics"},"translate_title":"股票追踪 | Attovia Therapeutics 在纳斯达克首次公开募股 2.89 亿美元后飙升 23.53%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ATTO":1},"content_text":"Shares of Attovia Therapeutics (ATTO) soared 23.53% in intraday trading on Wednesday, marking a strong debut on the Nasdaq after the company's upsized initial public offering.The biotech firm priced its IPO at $17.00 per share, the top of the marketed range, and increased the deal size to 17 million shares from the originally planned 12.5 million, raising approximately $289 million. The offering was managed by Morgan Stanley, Leerink Partners, Citigroup, and RBC Capital Markets.Pre-market indications had pointed to a robust open, with the stock expected to start trading between $20 and $24, reflecting heightened investor demand for Attovia's pipeline of immune-mediated disease therapies, including its lead program ATTO-1310 for chronic pruritic conditions.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}